| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |